3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
4
Gynecologic
2
CNS
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
653
Ovarian Neoplasms
441
Endometrial Neoplasms
290
Breast Neoplasms
179
Uterine Cervical Dysplasia
133
Neoplasms
86
Carcinoma, Ovarian Epithelial
80
Papillomavirus Infections
69
Prostatic Neoplasms
67
Uterine Neoplasms
66
Vulvar Neoplasms
64
Colorectal Neoplasms
59
Fallopian Tube Neoplasms
54
Colonic Neoplasms
47
Peritoneal Neoplasms
45
Pancreatic Neoplasms
45
Lung Neoplasms
45
Urinary Bladder Neoplasms
39
Vaginal Neoplasms
34
Gynecologic Cancer
33
Stomach Neoplasms
32
Head and Neck Neoplasms
31
Hereditary Breast and Ovarian Cancer Syndrome
27
Sarcoma
26
Rectal Neoplasms
26
Pelvic Neoplasms
26
Melanoma
25
Esophageal Neoplasms
25
Recurrence
24
Ovarian Cysts
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Hypersensitivity
×
Gynecologic
×
Clear all
NCT01837693
2025-06-26
NTCC2
Azienda USL Reggio Emilia - IRCCS
Phase NA
Completed
41,127 enrolled
NCT01663753
2019-01-07
ERRICC
Hospices Civils de Lyon
Phase NA
Completed
146 enrolled